AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Dollar General lifts annual comparable sales growth target
(Reuters) - Dollar General on Tuesday raised its annual sales forecast after topping quarterly sales expectations, helped by robust demand for affordable everyday essentials at its stores amid still-h...
- June 03, 2025 04:03 AM PDT
- EODHD
Aces Quality Management Champions Commitment To Lending Excellence At Aces Engage 2025
DENVER, Colo., June 3, 2025 (SEND2PRESS NEWSWIRE) -- ACES Quality Management® (ACES), the leading provider of enterprise quality management and control software for the financial services industr...
- June 03, 2025 04:00 AM PDT
- Send2Press
Craig Leabig Of Informative Research Named Housingwire 2025 Marketing Leader
GARDEN GROVE, Calif., June 3, 2025 (SEND2PRESS NEWSWIRE) -- Informative Research, a premier technology provider delivering data-driven credit and verification solutions to the lending community, today...
- June 03, 2025 04:00 AM PDT
- Send2Press
Hewlett Packard Enterprise Q2 25 Earnings Conference Call At 5:00 PM ET
(RTTNews) - Hewlett Packard Enterprise (HPE) will host a conference call at 5:00 PM ET on June 3, 2025, to discuss Q2 25 earnings results. To access the live webcast, log on to https://event.choruscal...
- June 03, 2025 04:00 AM PDT
- EODHD
Dark Matter Technologies Announces Comprehensive Eclosing Integration For Its Nova Los Platform
JACKSONVILLE, Fla., June 3, 2025 (SEND2PRESS NEWSWIRE) -- Dark Matter Technologies (Dark Matter®), an innovative leader in mortgage technology, announced today that the NOVA loan origination syst...
- June 03, 2025 04:00 AM PDT
- Send2Press
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
NEWTOWN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to t...
- June 03, 2025 04:00 AM PDT
- EODHD
BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual Meeting
Median PFS at 6.8 months, Disease Control Rate of 77.3%, 15 months OS% at 78% in Metastatic NSCLC Patients after Progression on PD-1/L1 Therapies FLORHAM PARK, N.J., June 03, 2025 (GLOBE NEWSWIRE) --...
- June 03, 2025 04:00 AM PDT
- EODHD
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
PRINCETON, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the publication of a post-hoc analysis of data from the ERT-experienced cohort of the PROPEL stud...
- June 03, 2025 04:00 AM PDT
- EODHD
Dollar General: Fiscal Q1 Earnings Snapshot
GOODLETTSVILLE, Tenn. (AP) — GOODLETTSVILLE, Tenn. (AP) — Dollar General Corp. (DG) on Tuesday reported fiscal first-quarter earnings of $391.9 million. The Goodlettsville, Tennessee-based company sai...
- June 03, 2025 03:57 AM PDT
- EODHD
Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025
Coloplast A/S The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport) Ellehammersvej 20, 2770 Kastrup from 10.30 - 17.00 CEST (Central European Summer Time) Colopl...
- June 03, 2025 03:57 AM PDT
- EODHD